The Traderszone Network

Published in TZ Latest News 27 March, 2017 by The TZ Newswire Staff

Foamix Acne Drug Fails Late-Stage Study

Foamix Pharmaceuticals stock hit a 52-week low on failure of FMX101 drug a Phase 3 study.